<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Multiple Sclerosis Management Algorithm | NICE CKS</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        :root {
            --assessment: #3b82f6;
            --diagnosis: #8b5cf6;
            --treatment: #10b981;
            --followup: #f59e0b;
            --urgent: #ef4444;
            --caution: #f97316;
            --stable: #10b981;
            --bg: #f8fafc;
            --card-bg: #ffffff;
            --text: #1e293b;
            --text-light: #64748b;
            --border: #e2e8f0;
            --shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.1), 0 2px 4px -1px rgba(0, 0, 0, 0.06);
            --shadow-lg: 0 10px 15px -3px rgba(0, 0, 0, 0.1), 0 4px 6px -2px rgba(0, 0, 0, 0.05);
        }

        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.6;
            scroll-behavior: smooth;
        }

        .header {
            background: linear-gradient(135deg, #1e40af 0%, #3b82f6 100%);
            color: white;
            padding: 2rem;
            text-align: center;
            box-shadow: var(--shadow);
            position: sticky;
            top: 0;
            z-index: 1000;
        }

        .header h1 {
            font-size: 1.8rem;
            margin-bottom: 0.5rem;
            font-weight: 700;
        }

        .header p {
            opacity: 0.9;
            font-size: 0.95rem;
        }

        .container {
            max-width: 1400px;
            margin: 0 auto;
            display: grid;
            grid-template-columns: 280px 1fr;
            gap: 1.5rem;
            padding: 1.5rem;
        }

        .sidebar {
            position: sticky;
            top: 120px;
            height: fit-content;
            background: var(--card-bg);
            border-radius: 12px;
            padding: 1.5rem;
            box-shadow: var(--shadow);
            transition: all 0.3s ease;
        }

        .sidebar h3 {
            font-size: 1.1rem;
            margin-bottom: 1rem;
            color: var(--text);
            font-weight: 600;
            display: flex;
            align-items: center;
            gap: 0.5rem;
        }

        .progress-item {
            display: flex;
            align-items: center;
            padding: 0.75rem;
            margin-bottom: 0.5rem;
            border-radius: 8px;
            cursor: pointer;
            transition: all 0.3s ease;
            font-size: 0.9rem;
            position: relative;
        }

        .progress-item::before {
            content: '';
            width: 4px;
            height: 100%;
            background: transparent;
            position: absolute;
            left: 0;
            top: 0;
            border-radius: 0 4px 4px 0;
            transition: all 0.3s ease;
        }

        .progress-item.active::before {
            background: var(--active-color);
        }

        .progress-item:hover {
            background: rgba(0, 0, 0, 0.05);
            transform: translateX(4px);
        }

        .progress-item.active {
            background: rgba(0, 0, 0, 0.05);
            font-weight: 600;
        }

        .progress-icon {
            width: 20px;
            height: 20px;
            margin-right: 0.75rem;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 6px;
            color: white;
            font-size: 0.8rem;
            font-weight: bold;
        }

        .main-content {
            padding: 0;
        }

        .section {
            margin-bottom: 1.5rem;
            opacity: 0;
            animation: fadeIn 0.6s ease forwards;
        }

        .section:nth-child(1) { animation-delay: 0.1s; }
        .section:nth-child(2) { animation-delay: 0.2s; }
        .section:nth-child(3) { animation-delay: 0.3s; }
        .section:nth-child(4) { animation-delay: 0.4s; }

        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(20px); }
            to { opacity: 1; transform: translateY(0); }
        }

        .step-card {
            background: var(--card-bg);
            border-radius: 16px;
            box-shadow: var(--shadow);
            overflow: hidden;
            transition: all 0.3s ease;
            cursor: pointer;
        }

        .step-card:hover {
            box-shadow: var(--shadow-lg);
            transform: translateY(-4px);
        }

        .step-card.expanded {
            box-shadow: var(--shadow-lg);
        }

        .card-header {
            background: linear-gradient(135deg, var(--color-start), var(--color-end));
            color: white;
            padding: 1.5rem;
            display: flex;
            align-items: center;
            justify-content: space-between;
            transition: all 0.3s ease;
        }

        .card-title {
            display: flex;
            align-items: center;
            gap: 1rem;
            font-size: 1.3rem;
            font-weight: 600;
        }

        .card-icon {
            width: 48px;
            height: 48px;
            background: rgba(255, 255, 255, 0.2);
            border-radius: 12px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.5rem;
        }

        .expand-icon {
            font-size: 1.2rem;
            transition: transform 0.3s ease;
        }

        .step-card.expanded .expand-icon {
            transform: rotate(180deg);
        }

        .card-content {
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.5s ease;
        }

        .step-card.expanded .card-content {
            max-height: 3000px;
        }

        .content-inner {
            padding: 1.5rem;
        }

        .subsection {
            margin-bottom: 1.5rem;
            padding-bottom: 1.5rem;
            border-bottom: 1px solid var(--border);
        }

        .subsection:last-child {
            border-bottom: none;
            margin-bottom: 0;
            padding-bottom: 0;
        }

        .subsection h4 {
            color: var(--text);
            margin-bottom: 0.75rem;
            font-size: 1.1rem;
            font-weight: 600;
            display: flex;
            align-items: center;
            gap: 0.5rem;
        }

        .alert-box {
            background: #f0f9ff;
            border-left: 4px solid var(--color-start);
            padding: 1rem;
            margin: 1rem 0;
            border-radius: 6px;
        }

        .alert-box.urgent {
            background: #fef2f2;
            border-left-color: var(--urgent);
        }

        .alert-box.caution {
            background: #fff7ed;
            border-left-color: var(--caution);
        }

        .badge {
            display: inline-flex;
            align-items: center;
            gap: 0.25rem;
            padding: 0.25rem 0.5rem;
            border-radius: 20px;
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .badge-red {
            background: var(--urgent);
            color: white;
        }

        .badge-amber {
            background: var(--caution);
            color: white;
        }

        .badge-green {
            background: var(--stable);
            color: white;
        }

        .subsection ul {
            padding-left: 1.5rem;
            margin: 0.75rem 0;
        }

        .subsection li {
            margin-bottom: 0.5rem;
            position: relative;
        }

        .subsection li::marker {
            color: var(--color-start);
        }

        .drug-info {
            background: #f8fafc;
            border: 1px solid var(--border);
            border-radius: 8px;
            padding: 1rem;
            margin: 0.75rem 0;
        }

        .drug-info strong {
            color: var(--text);
            display: block;
            margin-bottom: 0.5rem;
        }

        .footer-actions {
            position: fixed;
            bottom: 2rem;
            right: 2rem;
            display: flex;
            gap: 1rem;
            z-index: 100;
        }

        .btn {
            background: var(--color-primary);
            color: white;
            border: none;
            padding: 0.75rem 1.5rem;
            border-radius: 8px;
            cursor: pointer;
            font-size: 0.9rem;
            font-weight: 600;
            transition: all 0.3s ease;
            box-shadow: var(--shadow);
        }

        .btn:hover {
            transform: translateY(-2px);
            box-shadow: var(--shadow-lg);
        }

        @media (max-width: 1024px) {
            .container {
                grid-template-columns: 220px 1fr;
                gap: 1rem;
                padding: 1rem;
            }
            
            .card-title {
                font-size: 1.1rem;
            }
            
            .card-icon {
                width: 40px;
                height: 40px;
                font-size: 1.2rem;
            }
        }

        @media (max-width: 768px) {
            .container {
                grid-template-columns: 1fr;
            }
            
            .sidebar {
                position: relative;
                top: 0;
                order: 2;
            }
            
            .main-content {
                order: 1;
            }
            
            .header h1 {
                font-size: 1.5rem;
            }
        }

        .assessment { --color-start: #3b82f6; --color-end: #60a5fa; --active-color: #3b82f6; }
        .diagnosis { --color-start: #8b5cf6; --color-end: #a78bfa; --active-color: #8b5cf6; }
        .treatment { --color-start: #10b981; --color-end: #34d399; --active-color: #10b981; }
        .followup { --color-start: #f59e0b; --color-end: #fbbf24; --active-color: #f59e0b; }

        .highlight {
            background: linear-gradient(120deg, #a5f3fc 0%, #67e8f9 100%);
            padding: 0 0.25rem;
            border-radius: 4px;
            font-weight: 600;
        }
    </style>
</head>
<body>
    <header class="header">
        <h1>Multiple Sclerosis Management Algorithm</h1>
        <p>NICE Clinical Knowledge Summaries (CKS) | Last Revised May 2024 | For Adults (18+)</p>
    </header>

    <div class="container">
        <aside class="sidebar" id="sidebar">
            <h3>
                <span>üìä</span>
                Progress
            </h3>
            <div class="progress-item active" data-section="assessment">
                <div class="progress-icon" style="background: #3b82f6;">A</div>
                <span>Assessment</span>
            </div>
            <div class="progress-item" data-section="diagnosis">
                <div class="progress-icon" style="background: #8b5cf6;">D</div>
                <span>Diagnosis</span>
            </div>
            <div class="progress-item" data-section="treatment">
                <div class="progress-icon" style="background: #10b981;">T</div>
                <span>Treatment</span>
            </div>
            <div class="progress-item" data-section="followup">
                <div class="progress-icon" style="background: #f59e0b;">F</div>
                <span>Follow-up</span>
            </div>
        </aside>

        <main class="main-content">
            <!-- Assessment Section -->
            <section class="section">
                <div class="step-card assessment" data-step="assessment">
                    <div class="card-header">
                        <div class="card-title">
                            <div class="card-icon">üß†</div>
                            <span>Assessment & Initial Presentation</span>
                        </div>
                        <div class="expand-icon">‚ñº</div>
                    </div>
                    <div class="card-content">
                        <div class="content-inner">
                            <div class="subsection">
                                <h4>When to Suspect Multiple Sclerosis</h4>
                                <div class="alert-box">
                                    <strong>Typical Age:</strong> 20-50 years (can present <0.5% aged ‚â•60)
                                </div>
                                <div class="alert-box caution">
                                    <span class="badge badge-amber">‚ö†Ô∏è Caution</span>
                                    <strong>Do NOT routinely suspect MS if:</strong> Main symptoms are fatigue, depression, or dizziness without focal neurological symptoms/signs
                                </div>
                                <ul>
                                    <li>History of previous neurological symptoms</li>
                                    <li>Symptoms evolve over >24 hours, persist days/weeks, then improve</li>
                                    <li>MS can affect nearly any part of CNS</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Common Initial Presentations</h4>
                                
                                <div class="alert-box urgent">
                                    <span class="badge badge-red">üö® Urgent</span>
                                    <strong>Optic Neuritis:</strong> Bilateral optic neuritis requires urgent exclusion of neuromyelitis optica
                                </div>
                                
                                <h5>1. Optic Neuritis (20-30% of initial presentations)</h5>
                                <ul>
                                    <li>Partial/total unilateral visual loss developing over days</li>
                                    <li>Pain behind eye (especially on eye movement)</li>
                                    <li>Loss of colour discrimination (particularly reds)</li>
                                    <li>Fundoscopy often normal; may see pale/swollen disc</li>
                                    <li>Relative afferent pupillary defect</li>
                                </ul>

                                <h5>2. Transverse Myelitis</h5>
                                <ul>
                                    <li>Sensory symptoms (paraesthesia) or motor symptoms (weakness) below inflammation level</li>
                                    <li>Develop over hours/days</li>
                                    <li>Tight band sensation around trunk at inflammation level</li>
                                    <li>Lhermitte's phenomenon (shock-like sensation on neck flexion)</li>
                                    <li>Urinary symptoms: urgency, frequency, retention</li>
                                </ul>

                                <h5>3. Cerebellar-Related Symptoms</h5>
                                <ul>
                                    <li>Ataxia, vertigo, clumsiness, dysmetria</li>
                                    <li>Abnormalities with finger-to-nose testing</li>
                                    <li>Walking heel-to-toe difficulties</li>
                                </ul>

                                <h5>4. Brainstem Syndromes</h5>
                                <ul>
                                    <li>Eye movement abnormalities ‚Üí diplopia, oscillopsia, nystagmus, internuclear ophthalmoplegia</li>
                                    <li>Bulbar muscle problems ‚Üí dysarthria, dysphagia</li>
                                    <li>Ataxia</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Key Clinical Features</h4>
                                <ul>
                                    <li><strong>Fatigue:</strong> Affects >80%, may precede onset by years</li>
                                    <li><strong>Spasticity:</strong> Affects up to 80%, ranges from mild tightness to severe contractures</li>
                                    <li><strong>Ataxia/Tremor:</strong> Common, severe disabling tremor in ~6%</li>
                                    <li><strong>Visual Problems:</strong> Optic neuritis, internuclear ophthalmoplegia, nystagmus, diplopia</li>
                                    <li><strong>Reduced Mobility:</strong> 85% report gait disturbance as main complaint</li>
                                    <li><strong>Pain:</strong> Prevalence 29-86% (neuropathic or musculoskeletal)</li>
                                    <li><strong>Bladder Problems:</strong> >90% in progressive MS</li>
                                    <li><strong>Sexual Dysfunction:</strong> 50-90% men, 40-80% women</li>
                                    <li><strong>Mental Health:</strong> Depression/anxiety up to 50% lifetime prevalence</li>
                                    <li><strong>Cognitive Impairment:</strong> 43-70% during disease course</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Risk Factors</h4>
                                <ul>
                                    <li><strong>Genetics:</strong> Complex; >200 alleles contribute small risk effects</li>
                                    <li><strong>Vitamin D deficiency:</strong> May have immunomodulatory role</li>
                                    <li><strong>Cigarette smoking:</strong> Increases risk and disease progression</li>
                                    <li><strong>Diet/Obesity:</strong> Early life obesity associated with 2-fold increase</li>
                                    <li><strong>Latitude:</strong> Prevalence increases with distance from equator</li>
                                    <li><strong>EBV infection:</strong> May have disease-triggering role</li>
                                    <li><strong>Female gender:</strong> 2-3x more common in women</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </section>

            <!-- Diagnosis Section -->
            <section class="section">
                <div class="step-card diagnosis" data-step="diagnosis">
                    <div class="card-header">
                        <div class="card-title">
                            <div class="card-icon">üîç</div>
                            <span>Diagnosis & Confirmation</span>
                        </div>
                        <div class="expand-icon">‚ñº</div>
                    </div>
                    <div class="card-content">
                        <div class="content-inner">
                            <div class="subsection">
                                <h4>Confirming the Diagnosis</h4>
                                <div class="alert-box urgent">
                                    <span class="badge badge-red">üö® Immediate</span>
                                    <strong>Refer promptly to consultant neurologist</strong> - Early diagnosis and treatment may improve prognosis
                                </div>
                                <ul>
                                    <li>Only a consultant neurologist should diagnose MS using revised McDonald criteria</li>
                                    <li>Establish lesions at different times and locations (RRMS)</li>
                                    <li>Establish progressive deterioration over ‚â•1 year (PPMS)</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Diagnosing a Relapse</h4>
                                <div class="alert-box">
                                    <strong>Relapse Definition:</strong> New/worsening symptoms lasting >24 hours, after stable period of ‚â•1 month, in absence of infection/other cause
                                </div>
                                <ul>
                                    <li>Rule out infection (especially UTI, respiratory)</li>
                                    <li>Discriminate between relapse vs disease fluctuations/progression</li>
                                    <li>Consider other conditions with similar features</li>
                                    <li>Do NOT routinely diagnose relapse if symptoms >3 months</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Differential Diagnosis</h4>
                                <ul>
                                    <li><strong>Demyelinating diseases:</strong> Neuromyelitis optica (urgent!), transverse myelitis, ADEM</li>
                                    <li><strong>Metabolic:</strong> Vitamin B12 deficiency, diabetes, hypocalcaemia, hypothyroidism</li>
                                    <li><strong>Infections:</strong> Lyme disease, syphilis, HIV, tropical spastic paraparesis</li>
                                    <li><strong>Vascular:</strong> Primary CNS vasculitis, ischaemic stroke</li>
                                    <li><strong>Systemic inflammatory:</strong> SLE, Beh√ßet's, sarcoidosis</li>
                                    <li><strong>Neoplastic:</strong> Primary/metastatic lesions, paraneoplastic syndromes</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Disease Patterns</h4>
                                <ul>
                                    <li><strong>RRMS (85% at onset):</strong> Episodes of relapse/remission</li>
                                    <li><strong>SPMS:</strong> Gradual accumulation of disability, relapses become less frequent</li>
                                    <li><strong>PPMS (10-15%):</strong> Steady progression from onset without remissions</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Specialist Team Role</h4>
                                <ul>
                                    <li>Confirm diagnosis using McDonald criteria</li>
                                    <li>Consider disease-modifying therapy (DMT)</li>
                                    <li>Organize multidisciplinary management</li>
                                    <li>Provide support at diagnosis (NICE Quality Standard)</li>
                                    <li>Face-to-face follow-up within 6 weeks</li>
                                    <li>Annual comprehensive review</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </section>

            <!-- Treatment Section -->
            <section class="section">
                <div class="step-card treatment" data-step="treatment">
                    <div class="card-header">
                        <div class="card-title">
                            <div class="card-icon">üíä</div>
                            <span>Treatment & Management</span>
                        </div>
                        <div class="expand-icon">‚ñº</div>
                    </div>
                    <div class="card-content">
                        <div class="content-inner">
                            <div class="subsection">
                                <h4>Managing a Relapse</h4>
                                <div class="alert-box urgent">
                                    <span class="badge badge-red">üö® Timely</span>
                                    <strong>Steroid treatment:</strong> Offer as early as possible, within 14 days of symptom onset
                                </div>
                                <ul>
                                    <li>Rule out infection before treating</li>
                                    <li>Consider hospital admission if severe, comorbidities, or oral steroids failed</li>
                                    <li>Standard treatment: <span class="highlight">Oral methylprednisolone 0.5g daily for 5 days</span></li>
                                    <li>Do NOT use lower dose than above</li>
                                    <li><strong>Benefits:</strong> Reduces relapse duration by average 13 days, may reduce severity</li>
                                    <li><strong>Risks:</strong> Mental health effects (depression, confusion, agitation), worsening glucose control</li>
                                    <li>Do NOT give home supply for future self-administration</li>
                                    <li>Each relapse should be discussed with specialist team</li>
                                    <li>Expected recovery: significant improvement within 2-3 months, can continue up to 12 months</li>
                                    <li>Residual disability occurs in 30-50% of relapses</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Fatigue Management</h4>
                                <ul>
                                    <li>Assess for sleep difficulties, anxiety, depression, anaemia, thyroid disease</li>
                                    <li>Explain precipitating factors: heat, overexertion, stress</li>
                                    <li>Advise planning activities, prioritizing, regular short rests</li>
                                    <li>Encourage regular aerobic, balance, stretching exercises including yoga</li>
                                    <li><strong>Specialist options:</strong>
                                        <ul>
                                            <li>Mindfulness-based training</li>
                                            <li>Cognitive behavioural therapy (CBT)</li>
                                            <li>Fatigue management programmes</li>
                                            <li>Supervised exercise programmes</li>
                                            <li>Vestibular rehabilitation</li>
                                        </ul>
                                    </li>
                                    <li><strong>Drug treatment (specialist):</strong>
                                        <ul>
                                            <li>Amantadine (off-label) - may help but not effective for all</li>
                                            <li>Modafinil (off-label) - unless pregnancy likely/planned</li>
                                            <li>SSRIs (off-label) - lowest effective dose</li>
                                        </ul>
                                    </li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Spasticity Management</h4>
                                <ul>
                                    <li>Assess/treat aggravating factors: skin irritation, posture, constipation, infections, pain</li>
                                    <li><strong>Warning:</strong> Some patients use spasticity for standing/walking - treatment may worsen function</li>
                                    <li><strong>First-line:</strong> Baclofen (see prescribing info below)</li>
                                    <li><strong>Second-line:</strong> Gabapentin if baclofen not tolerated/inadequate</li>
                                    <li>Increase dose gradually every 2 weeks</li>
                                    <li>Try maximum tolerated dose before stopping</li>
                                    <li>Combination therapy may be tried</li>
                                    <li>Encourage self-management within agreed limits</li>
                                    <li>Refer to physiotherapy</li>
                                    <li>Refer to specialist spasticity service if insufficient control</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Ataxia & Tremor Management</h4>
                                <ul>
                                    <li>No specific recommended treatment for MS-related tremor/ataxia</li>
                                    <li>Refer to physiotherapist for posture advice</li>
                                    <li>Refer to occupational therapist for:
                                        <ul>
                                            <li>Activity adaptations (eating, drinking)</li>
                                            <li>Assistive technology</li>
                                            <li>Computer modifications</li>
                                        </ul>
                                    </li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Oscillopsia Management</h4>
                                <ul>
                                    <li>Can cause significant distress and functional limitation</li>
                                    <li><strong>First-line (specialist):</strong> Gabapentin (off-label)</li>
                                    <li><strong>Second-line (specialist):</strong> Memantine (off-label)</li>
                                    <li>If treatment fails: refer to neuro-ophthalmologist</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Mobility Problems</h4>
                                <ul>
                                    <li>Assess/treat aggravating factors: fatigue, spasticity, visual problems</li>
                                    <li>Refer for assessment by rehabilitation specialists/physiotherapists</li>
                                    <li>Consider:
                                        <ul>
                                            <li>Supervised exercise programmes</li>
                                            <li>Vestibular rehabilitation</li>
                                            <li>Mobility aids</li>
                                            <li>Home adaptations</li>
                                        </ul>
                                    </li>
                                    <li>Encourage continued exercise after programme ends</li>
                                    <li>Fampridine may benefit some but not cost-effective currently</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Mental Health Management</h4>
                                <ul>
                                    <li><strong>Depression/Anxiety:</strong> Manage as usual, consider medication interactions</li>
                                    <li><strong>CBT:</strong> Offer for adjustment difficulties</li>
                                    <li><strong>Emotional lability:</strong> Consider amitriptyline (specialist)</li>
                                    <li><strong>Cognitive impairment:</strong>
                                        <ul>
                                            <li>65% prevalence in MS</li>
                                            <li>Assess for anxiety, depression, sleep, fatigue</li>
                                            <li>Refer to OT and neuropsychologist</li>
                                        </ul>
                                    </li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Pain Management</h4>
                                <ul>
                                    <li><strong>Musculoskeletal pain:</strong> Common, secondary to mobility/posture problems
                                        <ul>
                                            <li>Refer to physiotherapy</li>
                                            <li>Consider NSAIDs (see CKS guidelines)</li>
                                        </ul>
                                    </li>
                                    <li><strong>Neuropathic pain:</strong> See NICE neuropathic pain guidance
                                        <ul>
                                            <li>Refer to pain services if appropriate</li>
                                        </ul>
                                    </li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Sexual Problems</h4>
                                <ul>
                                    <li>Common but under-reported (50-90% men, 40-80% women)</li>
                                    <li>Thorough assessment required</li>
                                    <li>Discuss/refer to secondary care</li>
                                    <li>Consider medication for erectile dysfunction</li>
                                    <li>Offer relationship or psychosexual counseling</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Bladder Problems</h4>
                                <div class="alert-box">
                                    <strong>Complex management:</strong> Discuss with MS team, refer to urology/neurourology/urogynaecology
                                </div>
                                <ul>
                                    <li>Storage dysfunction most common: urinary frequency, urgency, incontinence</li>
                                    <li>Urinary urgency (62%), frequency (50%), urge incontinence (45%), nocturia (33%)</li>
                                    <li>See CKS topics on LUTS, urinary incontinence, UTI</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Pregnancy Considerations</h4>
                                <ul>
                                    <li>Relapse rates reduce during pregnancy</li>
                                    <li>~25% experience relapse in first 3 months postpartum</li>
                                    <li>Pregnancy does not increase disease progression risk</li>
                                    <li>If planning pregnancy:
                                        <ul>
                                            <li>Discuss with specialist team</li>
                                            <li>Review fertility, child MS risk, vitamin D use</li>
                                            <li>Review medication safety (some DMTs contraindicated)</li>
                                            <li>Discuss pain relief, breastfeeding, fatigue management</li>
                                        </ul>
                                    </li>
                                    <li>UTIs more frequent in pregnancy - advise prompt treatment</li>
                                    <li>Increased risk postpartum depression - ensure appropriate management</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </section>

            <!-- Follow-up Section -->
            <section class="section">
                <div class="step-card followup" data-step="followup">
                    <div class="card-header">
                        <div class="card-title">
                            <div class="card-icon">üìã</div>
                            <span>Follow-up & Ongoing Care</span>
                        </div>
                        <div class="expand-icon">‚ñº</div>
                    </div>
                    <div class="card-content">
                        <div class="content-inner">
                            <div class="subsection">
                                <h4>General Management Principles</h4>
                                <ul>
                                    <li>Patient under care of consultant neurologist and multidisciplinary MS team</li>
                                    <li>MS nurses are key link between primary/secondary care and community services</li>
                                    <li>Offer lifestyle advice for general good health:
                                        <ul>
                                            <li>Encourage regular exercise - beneficial for MS</li>
                                            <li>Advise smoking cessation - may increase disability progression</li>
                                            <li>Optimize comorbidities (depression, anxiety, vascular risk factors)</li>
                                            <li>Be aware of medication interactions with DMTs</li>
                                        </ul>
                                    </li>
                                    <li>Vaccinations:
                                        <ul>
                                            <li>Live vaccines may be contraindicated with DMTs - seek specialist advice</li>
                                            <li>Offer flu vaccination per national guidance</li>
                                            <li>Discuss possible relapse risk after flu vaccination in RRMS</li>
                                        </ul>
                                    </li>
                                    <li>Provide information:
                                        <ul>
                                            <li>Patient organizations: MS Trust, MS Society</li>
                                            <li>DVLA notification requirements</li>
                                            <li>Legal rights (social care, employment, benefits)</li>
                                            <li>Social care needs assessment</li>
                                        </ul>
                                    </li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Monitoring & Review</h4>
                                <div class="alert-box">
                                    <span class="badge badge-green">‚úì Annual</span>
                                    <strong>Comprehensive review:</strong> At least annually by healthcare professionals with MS expertise
                                </div>
                                <ul>
                                    <li>Usually arranged in secondary care</li>
                                    <li>During any consultation, check review occurred in preceding 12 months</li>
                                    <li>Discuss cognitive problems and importance of regular assessment</li>
                                    <li>Provide information on advance care planning and power of attorney</li>
                                    <li>Manage symptoms and end-of-life care in conjunction with MS team and palliative care services</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Prognosis & Counselling</h4>
                                <ul>
                                    <li>No cure currently available</li>
                                    <li>Prognosis varies widely</li>
                                    <li>Neurological disability gradually accumulates over time for most</li>
                                    <li><strong>RRMS:</strong> 85-90% start with relapsing course; 10-20 years after onset, >50% develop SPMS</li>
                                    <li><strong>PPMS:</strong> 10-15% have progressive course from onset; faster progression to disability</li>
                                    <li>Poor prognostic factors:
                                        <ul>
                                            <li>Male sex, older age at onset</li>
                                            <li>Multifocal presentation</li>
                                            <li>Pyramidal/cerebellar involvement</li>
                                            <li>Partial recovery from relapses</li>
                                            <li>High relapse rate in first 2 years</li>
                                            <li>High lesion burden on MRI</li>
                                        </ul>
                                    </li>
                                    <li>Early intervention with DMTs may reduce relapse risk and delay disability</li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>Quality of Life & Support</h4>
                                <ul>
                                    <li>MS is most common cause of serious physical disability in working-age adults</li>
                                    <li>Significant detrimental effect on quality of life for patients and families/carers</li>
                                    <li>Provide psychological and social support throughout disease course</li>
                                    <li>Encourage engagement with patient organizations for peer support</li>
                                    <li>Address employment issues early</li>
                                    <li>Consider referral to:
                                        <ul>
                                            <li>Occupational therapy for daily living adaptations</li>
                                            <li>Neuropsychology for cognitive issues</li>
                                            <li>Pain services</li>
                                            <li>Psychosexual counseling</li>
                                        </ul>
                                    </li>
                                </ul>
                            </div>

                            <div class="subsection">
                                <h4>When to Re-refer to Specialist</h4>
                                <div class="alert-box urgent">
                                    <span class="badge badge-red">üö® Urgent</span>
                                    <strong>Neuromyelitis optica:</strong> High mortality if not diagnosed/treated quickly
                                </div>
                                <ul>
                                    <li>Severe relapse requiring hospital admission</li>
                                    <li>New or worsening symptoms not responding to treatment</li>
                                    <li>Pregnancy planning or confirmed pregnancy</li>
                                    <li>Significant cognitive decline</li>
                                    <li>Mental health crisis</li>
                                    <li>Uncertainty about diagnosis</li>
                                    <li>Consideration of disease-modifying therapy changes</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </section>

            <!-- Prescribing Information -->
            <section class="section">
                <div class="step-card treatment" data-step="prescribing">
                    <div class="card-header">
                        <div class="card-title">
                            <div class="card-icon">üíä</div>
                            <span>Prescribing Information - Key Drugs</span>
                        </div>
                        <div class="expand-icon">‚ñº</div>
                    </div>
                    <div class="card-content">
                        <div class="content-inner">
                            <div class="subsection">
                                <h4>Baclofen (for Spasticity)</h4>
                                <div class="drug-info">
                                    <strong>Dosing:</strong>
                                    <ul>
                                        <li>Start: 5mg three times daily</li>
                                        <li>Maintenance: Usually 60mg/day in three divided doses</li>
                                        <li>Maximum: 100mg/day in divided doses</li>
                                        <li>Adjust based on individual response</li>
                                        <li>If no benefit after 6 weeks at maximum dose, stop</li>
                                        <li>Withdrawal: Reduce gradually over ‚â•1-2 weeks</li>
                                    </ul>
                                </div>
                                
                                <div class="drug-info">
                                    <strong>Cautions:</strong>
                                    <ul>
                                        <li>Cerebrovascular disease, Parkinson's</li>
                                        <li>Diabetes, elderly</li>
                                        <li>Respiratory, hepatic, renal impairment</li>
                                        <li>History of peptic ulceration</li>
                                        <li>Epilepsy, severe psychiatric disorders</li>
                                        <li>Risk of misuse, abuse, dependence</li>
                                        <li>Pregnancy: only if benefit outweighs risk</li>
                                    </ul>
                                </div>

                                <div class="drug-info">
                                    <strong>Adverse Effects:</strong>
                                    <ul>
                                        <li>Common: drowsiness, nausea, fatigue, confusion, dizziness, hallucination, depression</li>
                                        <li>Rare: abdominal pain, erectile dysfunction, hepatic dysfunction</li>
                                        <li>Withdrawal symptoms: anxiety, psychosis, hyperthermia, seizures, tachycardia</li>
                                    </ul>
                                </div>

                                <div class="drug-info">
                                    <strong>Drug Interactions:</strong>
                                    <ul>
                                        <li>Alcohol, muscle relaxants, opiates, anxiolytics, hypnotics - increased sedation/respiratory depression</li>
                                        <li>TCAs - enhanced muscle relaxation, additive drowsiness</li>
                                        <li>Antihypertensives - potentiated hypotensive effect</li>
                                        <li>NSAIDs - may decrease baclofen excretion</li>
                                    </ul>
                                </div>
                            </div>

                            <div class="subsection">
                                <h4>Gabapentin (for Spasticity/Oscillopsia)</h4>
                                <div class="alert-box caution">
                                    <span class="badge badge-amber">‚ö†Ô∏è Class C Controlled</span>
                                    <strong>Important:</strong> Evaluate history of drug abuse before prescribing. Monitor for abuse and dependence.
                                </div>
                                <div class="drug-info">
                                    <strong>Considerations:</strong>
                                    <ul>
                                        <li>Off-label use for MS spasticity and oscillopsia</li>
                                        <li>Second-line after baclofen for spasticity</li>
                                        <li>First-line for oscillopsia</li>
                                        <li>See NICE neuropathic pain guidance for details</li>
                                    </ul>
                                </div>
                            </div>

                            <div class="subsection">
                                <h4>Methylprednisolone (for Relapses)</h4>
                                <div class="drug-info">
                                    <strong>Standard Regimen:</strong>
                                    <ul>
                                        <li>0.5g orally once daily for 5 days</li>
                                        <li>Do NOT use lower dose</li>
                                        <li>Offer within 14 days of symptom onset</li>
                                        <li>Reduces relapse duration by average 13 days</li>
                                    </ul>
                                </div>
                                <div class="drug-info">
                                    <strong>Complications:</strong>
                                    <ul>
                                        <li>Temporary mental health effects (depression, confusion, agitation)</li>
                                        <li>Worsening blood glucose control in diabetes</li>
                                        <li>Do NOT give supply for home self-administration</li>
                                    </ul>
                                </div>
                            </div>

                            <div class="subsection">
                                <h4>Amitriptyline (for Emotional Lability)</h4>
                                <div class="drug-info">
                                    <ul>
                                        <li>Off-label use for MS-related emotional lability</li>
                                        <li>See NICE neuropathic pain guidance for details</li>
                                        <li>Monitor for side effects: drowsiness, anticholinergic effects</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </section>
        </main>
    </div>

    <div class="footer-actions">
        <button class="btn" onclick="toggleAllSections()" style="background: var(--color-start);">
            <span id="expand-all-text">Expand All</span>
        </button>
        <button class="btn" onclick="window.print()" style="background: #64748b;">
            üñ®Ô∏è Print
        </button>
    </div>

    <script>
        // Initialize state
        let expandedSections = new Set();
        let allExpanded = false;
        
        // Load saved state
        function loadState() {
            const saved = localStorage.getItem('msAlgorithmState');
            if (saved) {
                try {
                    const state = JSON.parse(saved);
                    expandedSections = new Set(state.expandedSections || []);
                } catch (e) {
                    console.log('Could not load saved state');
                }
            }
        }
        
        // Save state
        function saveState() {
            const state = {
                expandedSections: Array.from(expandedSections),
                timestamp: new Date().toISOString()
            };
            localStorage.setItem('msAlgorithmState', JSON.stringify(state));
        }
        
        // Toggle card expansion
        function toggleCard(step) {
            const card = document.querySelector(`[data-step="${step}"]`);
            const isExpanded = expandedSections.has(step);
            
            if (isExpanded) {
                card.classList.remove('expanded');
                expandedSections.delete(step);
            } else {
                card.classList.add('expanded');
                expandedSections.add(step);
            }
            
            saveState();
            updateExpandAllButton();
        }
        
        // Expand/collapse all
        function toggleAllSections() {
            const cards = document.querySelectorAll('.step-card');
            const targetExpanded = !allExpanded;
            
            cards.forEach(card => {
                const step = card.dataset.step;
                if (targetExpanded) {
                    card.classList.add('expanded');
                    expandedSections.add(step);
                } else {
                    card.classList.remove('expanded');
                    expandedSections.delete(step);
                }
            });
            
            allExpanded = targetExpanded;
            saveState();
            updateExpandAllButton();
        }
        
        // Update expand all button
        function updateExpandAllButton() {
            const cards = document.querySelectorAll('.step-card');
            allExpanded = Array.from(cards).every(card => 
                expandedSections.has(card.dataset.step)
            );
            
            document.getElementById('expand-all-text').textContent = 
                allExpanded ? 'Collapse All' : 'Expand All';
        }
        
        // Progress sidebar navigation
        function initSidebar() {
            const progressItems = document.querySelectorAll('.progress-item');
            
            progressItems.forEach(item => {
                item.addEventListener('click', () => {
                    const section = item.dataset.section;
                    const targetCard = document.querySelector(`[data-step="${section}"]`);
                    
                    if (targetCard) {
                        targetCard.scrollIntoView({ 
                            behavior: 'smooth', 
                            block: 'start' 
                        });
                        
                        // Highlight clicked item
                        progressItems.forEach(p => p.classList.remove('active'));
                        item.classList.add('active');
                    }
                });
            });
        }
        
        // Card click handlers
        function initCards() {
            const cards = document.querySelectorAll('.step-card');
            
            cards.forEach(card => {
                const header = card.querySelector('.card-header');
                const step = card.dataset.step;
                
                header.addEventListener('click', (e) => {
                    e.preventDefault();
                    toggleCard(step);
                });
            });
            
            // Restore expansion state
            expandedSections.forEach(step => {
                const card = document.querySelector(`[data-step="${step}"]`);
                if (card) {
                    card.classList.add('expanded');
                }
            });
            
            updateExpandAllButton();
        }
        
        // Smooth scroll observer for progress tracking
        function initScrollObserver() {
            const options = {
                rootMargin: '-20% 0px -60% 0px',
                threshold: 0
            };
            
            const observer = new IntersectionObserver((entries) => {
                entries.forEach(entry => {
                    if (entry.isIntersecting) {
                        const step = entry.target.dataset.step;
                        const progressItem = document.querySelector(`[data-section="${step}"]`);
                        
                        if (progressItem) {
                            document.querySelectorAll('.progress-item').forEach(p => 
                                p.classList.remove('active')
                            );
                            progressItem.classList.add('active');
                        }
                    }
                });
            }, options);
            
            document.querySelectorAll('.step-card').forEach(card => {
                observer.observe(card);
            });
        }
        
        // Search functionality
        function initSearch() {
            const searchBox = document.createElement('input');
            searchBox.type = 'text';
            searchBox.placeholder = 'Search algorithm...';
            searchBox.style.cssText = `
                position: fixed;
                top: 1rem;
                right: 1rem;
                padding: 0.5rem 1rem;
                border: 2px solid #e2e8f0;
                border-radius: 8px;
                font-size: 0.9rem;
                width: 250px;
                z-index: 1001;
            `;
            
            searchBox.addEventListener('input', (e) => {
                const query = e.target.value.toLowerCase();
                const cards = document.querySelectorAll('.step-card');
                
                if (!query) {
                    cards.forEach(card => {
                        card.style.display = 'block';
                        card.innerHTML = card.innerHTML.replace(/<mark>/g, '').replace(/<\/mark>/g, '');
                    });
                    return;
                }
                
                cards.forEach(card => {
                    const text = card.textContent.toLowerCase();
                    const isMatch = text.includes(query);
                    
                    if (isMatch) {
                        card.style.display = 'block';
                        // Highlight matches
                        const regex = new RegExp(query, 'gi');
                        card.innerHTML = card.innerHTML.replace(regex, (match) => 
                            `<mark style="background: #fef08a; padding: 0.1rem 0.2rem; border-radius: 3px;">${match}</mark>`
                        );
                    } else {
                        card.style.display = 'none';
                    }
                });
            });
            
            document.body.appendChild(searchBox);
        }
        
        // Initialize everything
        document.addEventListener('DOMContentLoaded', () => {
            loadState();
            initCards();
            initSidebar();
            initScrollObserver();
            initSearch();
        });
        
        // Keyboard shortcuts
        document.addEventListener('keydown', (e) => {
            if (e.ctrlKey || e.metaKey) {
                switch(e.key) {
                    case 'f':
                        e.preventDefault();
                        document.querySelector('input[type="text"]').focus();
                        break;
                    case 'p':
                        e.preventDefault();
                        window.print();
                        break;
                }
            }
        });
    </script>
</body>
</html>